RAC

1.74%

$1.47 race oncology ltd

Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage, page-95

First 95 Last

Share
Profile

Follow
IndexInvestor

8,645 Posts.

1427

01/07/22

20:42

Post #: 62328982
Share

Originally posted by variouscoffee: ↑

I find it a little strange that no-one has talked about what is missing from the announcement yet. First remember that "The highest impact journals have a policy of not publishing papers where the data has been previously released in any form." While I assume that there are some additional measures of cardio-protection that will provide further insight into this aspect of the opportunity, something larger is missing.

There has been zero information given regarding the efficacy of the combination in killing cancer cells... Is this what we will have to wait until publication for?

I am generally quite a reserved investor, but this sounds... large. I also note that the language in this announcement is different to all of our other positive results, almost giddy. I look forward to the paper being released.

Expand

There's nothing strange.
This experiment wasn't about cancer.
There were no cancers used.

To read about cancer efficacy of combinations, you need to read the previous announcements for AML, melanoma, kidney cancer, breast cancer, ovarian cancer.

Then you can put two and two together.
I guess the future journal article will do that.

Last edited by IndexInvestor: 01/07/22

RAC Price at posting: $2.20 Sentiment: Buy Disclosure: Held
25 Upvote

3 Great analysis

Reply

Top Stories

What each US election outcome would mean for Australian companies & investors

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Making money: How many microcaps should be in an investor's portfolio?

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

There are more pages in this discussion • 18 more messages in this thread...

First 95 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.47		Change 0.025(1.74%)		Mkt cap ! $249.7M

Open	High	Low	Value	Volume
$1.44	$1.48	$1.44	$25.63K	17.46K

Buyers (Bids)

No.	Vol.	Price($)
1	312	$1.47

Sellers (Offers)

Price($)	Vol.	No.
$1.48	354	1

View Market Depth

No.	Vol.	Price($)
1	312	1.465
1	2000	1.460
1	548	1.440
1	2046	1.420
3	14000	1.410

Price($)	Vol.	No.
1.480	11014	1
1.495	2500	1
1.500	4999	1
1.520	485	1
1.530	10000	1

Last trade - 16.10pm 01/11/2024 (20 minute delay)

RAC (ASX) Chart

Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage, page-95

What each US election outcome would mean for Australian companies & investors

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Making money: How many microcaps should be in an investor's portfolio?

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage, page-95

Top Stories

What each US election outcome would mean for Australian companies & investors

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Making money: How many microcaps should be in an investor's portfolio?

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News